Thus, we suggest that modulation of SRSF3 and hnRNPM expression and their splicing signature could represent a novel therapeutic opportunity for combined and less aggressive therapy in Ewing sarcoma. The gene discussed is SRSF3; the disease is Ewing sarcoma.